- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02130219
Clinical Value of Noninvasive Intracranial Pressure Measurement (Braincare)
Scientific Research and Development of Innovative Evidence Based Non-invasive Brain Diagnostic and Monitoring Solutions for Neurological and Traumatic Brain Injury Patients
Study Overview
Status
Conditions
Detailed Description
Study Type
Enrollment (Anticipated)
Phase
- Phase 2
- Phase 3
Contacts and Locations
Study Locations
-
-
-
Kaunas, Lithuania
- Recruiting
- Hospital of Lithuanian University of Health Sciences Kauno Klinikos
-
Contact:
- Kestutis Petrikonis, MD,PhD
- Email: kestutispetrikonis@yahoo.com
-
Principal Investigator:
- Kestutis Petrikonis, MD, PhD
-
Sub-Investigator:
- Vaidas Matijosaitis, MD, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Chronic daily headache with suspected idiopathic intracranial hypertension
- Diagnosed of suspected multiple sclerosis (MS)
- Intracranial hemorrhage/ stroke
Exclusion Criteria:
- Patient not able to understand information about the trial
- Uncooperative patient
- Intracranial hemorrhage volume <20 or >40ml
- Stroke area larger than 1/3 of the middle cerebral artery
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Chronic daily headache group
Patients with chronic daily headache with suspicion of intracranial hypertension selected. Selection based on clinical symptoms (headache description, leading symptoms)and para-clinical pathological findings (optical nerve papilla edema). Not enough evidence to diagnose any other headache type. Simultaneous CSF pressure measurements and non-invasive ICP measurement will be performed. Interventions: non-invasive intracranial pressure measurement; lumbar puncture and cerebrospinal fluid pressure measurement; brain MRI/CT. |
The noninvasive ICP measurement device Vittamed 205 aICP meter used in this study has been developed in Lithuania.
The method is based on two-depth transcranial Doppler technique for simultaneously measuring flow velocity pulsatilities in the intracranial and extracranial segments of the ophthalmic artery (OA).
These measurements are made while applying a series of small pressure steps to the tissues surrounding the eye-ball.
The intracranial segment of the OA is compressed by ICP and the extracranial segment of the OA is compressed by the externally applied pressure Pe.
Blood flow pulsatility parameters in both of these OA segments are monitored.Pulsatilities are approximately the same when Pe = ICP.
Two-depth TCD device is used as an indicator of the pressure balance point.
Other Names:
1.5 T MRI using T1 and T2 regimes, brain MRI angiography, performed for selected patients to analyze anatomical features of ophthalmic artery and optical nerves sheath diameter. Brain CT performed to evaluate hemorrhage and stroke volume.
Lumbar puncture performed in lateral decubitus position while knees and head flexed.
After local antiseptics and anesthesia puncture in lumbar 3/4 or 4/5 intervertebral space performed.
As CSF appears legs and head are relaxed and slightly straightened.
Spinal manometer graded 0-40 cm H₂O with stopcock connected to the needle.
CSF pressure monitored for 10 minutes and recorded.
CSF collected for diagnostic test.
Spinal needle Number 22 and Rocket Spinal Manometer Set (No. R55990) used for this study.
Other Names:
|
|
Experimental: Multiple sclerosis group
Multiple sclerosis (MS) group patients selected based on clinical symptoms and brain MRI changes typical for the disease. Diagnosis based on McDonalds criteria. CSF test for oligoclonal bands required as supporting diagnostic criteria. Patients selected with disease relapse symptoms. Simultaneous noninvasive ICP and CSF pressure measured. Interventions: non-invasive intracranial pressure measurement; lumbar puncture and cerebrospinal fluid pressure measurement; brain MRI/CT |
The noninvasive ICP measurement device Vittamed 205 aICP meter used in this study has been developed in Lithuania.
The method is based on two-depth transcranial Doppler technique for simultaneously measuring flow velocity pulsatilities in the intracranial and extracranial segments of the ophthalmic artery (OA).
These measurements are made while applying a series of small pressure steps to the tissues surrounding the eye-ball.
The intracranial segment of the OA is compressed by ICP and the extracranial segment of the OA is compressed by the externally applied pressure Pe.
Blood flow pulsatility parameters in both of these OA segments are monitored.Pulsatilities are approximately the same when Pe = ICP.
Two-depth TCD device is used as an indicator of the pressure balance point.
Other Names:
1.5 T MRI using T1 and T2 regimes, brain MRI angiography, performed for selected patients to analyze anatomical features of ophthalmic artery and optical nerves sheath diameter. Brain CT performed to evaluate hemorrhage and stroke volume.
Lumbar puncture performed in lateral decubitus position while knees and head flexed.
After local antiseptics and anesthesia puncture in lumbar 3/4 or 4/5 intervertebral space performed.
As CSF appears legs and head are relaxed and slightly straightened.
Spinal manometer graded 0-40 cm H₂O with stopcock connected to the needle.
CSF pressure monitored for 10 minutes and recorded.
CSF collected for diagnostic test.
Spinal needle Number 22 and Rocket Spinal Manometer Set (No. R55990) used for this study.
Other Names:
|
|
Experimental: Stroke group
Patients selected for this group have stroke/intracranial hemorrhage that might be complicated with intracranial hypertension. Stroke/intracranial hemorrhage diagnosed based on clinical findings and changes on brain CT/MRI. Patients with stroke less than 33% of middle cerebral artery territory included. Patients with intracranial hemorrhage 20-40 ml volume included. Patients unable to cooperate or sign informed consent excluded. Bilateral non-invasive ICP measurements performed. Results compared with brain MRI/CT lesion volume, mid-line shift. Interventions: non-invasive intracranial pressure measurement; brain MRI/CT |
The noninvasive ICP measurement device Vittamed 205 aICP meter used in this study has been developed in Lithuania.
The method is based on two-depth transcranial Doppler technique for simultaneously measuring flow velocity pulsatilities in the intracranial and extracranial segments of the ophthalmic artery (OA).
These measurements are made while applying a series of small pressure steps to the tissues surrounding the eye-ball.
The intracranial segment of the OA is compressed by ICP and the extracranial segment of the OA is compressed by the externally applied pressure Pe.
Blood flow pulsatility parameters in both of these OA segments are monitored.Pulsatilities are approximately the same when Pe = ICP.
Two-depth TCD device is used as an indicator of the pressure balance point.
Other Names:
1.5 T MRI using T1 and T2 regimes, brain MRI angiography, performed for selected patients to analyze anatomical features of ophthalmic artery and optical nerves sheath diameter. Brain CT performed to evaluate hemorrhage and stroke volume. |
|
Experimental: Normal pressure hydrocephalus group
Patients meeting normal pressure hydrocephalus diagnosis criteria selected to compare invasive CSF pressure versus non-invasive ICP. Interventions: non-invasive intracranial pressure measurement; lumbar puncture and cerebrospinal fluid pressure measurement; brain MRI/CT |
The noninvasive ICP measurement device Vittamed 205 aICP meter used in this study has been developed in Lithuania.
The method is based on two-depth transcranial Doppler technique for simultaneously measuring flow velocity pulsatilities in the intracranial and extracranial segments of the ophthalmic artery (OA).
These measurements are made while applying a series of small pressure steps to the tissues surrounding the eye-ball.
The intracranial segment of the OA is compressed by ICP and the extracranial segment of the OA is compressed by the externally applied pressure Pe.
Blood flow pulsatility parameters in both of these OA segments are monitored.Pulsatilities are approximately the same when Pe = ICP.
Two-depth TCD device is used as an indicator of the pressure balance point.
Other Names:
1.5 T MRI using T1 and T2 regimes, brain MRI angiography, performed for selected patients to analyze anatomical features of ophthalmic artery and optical nerves sheath diameter. Brain CT performed to evaluate hemorrhage and stroke volume.
Lumbar puncture performed in lateral decubitus position while knees and head flexed.
After local antiseptics and anesthesia puncture in lumbar 3/4 or 4/5 intervertebral space performed.
As CSF appears legs and head are relaxed and slightly straightened.
Spinal manometer graded 0-40 cm H₂O with stopcock connected to the needle.
CSF pressure monitored for 10 minutes and recorded.
CSF collected for diagnostic test.
Spinal needle Number 22 and Rocket Spinal Manometer Set (No. R55990) used for this study.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of participants with the results of noninvasive intracranial pressure measurement (with Vittamed 205 aICP meter) within clinically acceptable 4 mm Hg difference from invasively measured CSF pressure.
Time Frame: Simultaneous noninvasive ICP and CSF pressure measurements. All measurements will be collected within 20 months until 31 December 2014.
|
Brain MRI/CT data will be used to compare ocular nerve sheath diameter (in mm) and stroke/ intracerebral hemorrhage volume (in cubic cm) with CSF pressure and non-invasive ICP.
|
Simultaneous noninvasive ICP and CSF pressure measurements. All measurements will be collected within 20 months until 31 December 2014.
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Kestutis Petrikonis, Lithuanian University of Health Sciences
Publications and helpful links
General Publications
- Ragauskas A, Matijosaitis V, Zakelis R, Petrikonis K, Rastenyte D, Piper I, Daubaris G. Clinical assessment of noninvasive intracranial pressure absolute value measurement method. Neurology. 2012 May 22;78(21):1684-91. doi: 10.1212/WNL.0b013e3182574f50. Epub 2012 May 9.
- Ragauskas A, Bartusis L, Piper I, Zakelis R, Matijosaitis V, Petrikonis K, Rastenyte D. Improved diagnostic value of a TCD-based non-invasive ICP measurement method compared with the sonographic ONSD method for detecting elevated intracranial pressure. Neurol Res. 2014 Jul;36(7):607-14. doi: 10.1179/1743132813Y.0000000308. Epub 2014 Jan 12.
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CH-3-SMM-01/06
- BE-2-26 (Other Grant/Funding Number: Regional bioethics commitee)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intracranial Hypertension
-
University of ValenciaRecruitingIdiopathic Intracranial Hypertension (IIH)Spain
-
Danish Headache CenterOdense University HospitalRecruitingBenign Intracranial HypertensionDenmark
-
St. Joseph's Hospital and Medical Center, PhoenixBarrow Neurological InstituteSuspendedPseudotumor Cerebri | Idiopathic Intracranial Hypertension (IIH)United States
-
Assiut UniversityNot yet recruitingIdiopathic Intracranial Hypertension (IIH)Egypt
-
Weill Medical College of Cornell UniversityCompletedIdiopathic Intracranial Hypertension (IIH)United States
-
Assiut UniversityNot yet recruitingIIH - Idiopathic Intracranial Hypertension
-
Thomas Jefferson UniversityAmerican Headache SocietyRecruitingGlymphatic System | Idiopathic Intracranial Hypertension (IIH)United States
-
Hillel Yaffe Medical CenterUnknownPediatric Idiopathic Intracranial HypertensionIsrael
-
Acandis GmbHNot yet recruitingIdiopathic Intracranial Hypertension (IIH)
-
Beijing Tiantan HospitalRecruitingVenous Sinus Stenosis | Idiopathic Intracranial HypotensionChina
Clinical Trials on Non-invasive intracranial pressure measurement
-
Kantonsspital AarauCompleted
-
Braincare USA CorpFederal University of São Paulo; Universidade Federal de Sergipe; Federal University...Not yet recruitingStroke Hemorrhagic | Stroke Ischemic | Traumatic Brain Injury (TBI) PatientsBrazil
-
Kantonsspital AarauSuspendedStroke, AcuteSwitzerland
-
Biobeat Technologies Ltd.CompletedHypertension | Blood Pressure DisordersIsrael
-
Shanghai 10th People's HospitalUnknown
-
Philippe VAN DER LINDENCompleted
-
University of ValenciaRecruitingIntracranial Pressure IncreaseSpain
-
University Hospital, MontpellierRecruitingIdiopathic Intracranial HypertensionFrance
-
Sevim Şenol KarataşCompletedMechanical VentilationTurkey (Türkiye)
-
Charite University, Berlin, GermanyCompletedCesarean Section Complications | Cesarean Delivery Affecting Newborn | Cesarean Delivery Affecting FetusGermany